228 related articles for article (PubMed ID: 9695188)
1. Vav links antigen-receptor signaling to the actin cytoskeleton.
Fischer KD; Tedford K; Penninger JM
Semin Immunol; 1998 Aug; 10(4):317-27. PubMed ID: 9695188
[TBL] [Abstract][Full Text] [Related]
2. The guanine-nucleotide exchange factor Vav is a crucial regulator of B cell receptor activation and B cell responses to nonrepetitive antigens.
Bachmann MF; Nitschke L; Krawczyk C; Tedford K; Ohashi PS; Fischer KD; Penninger JM
J Immunol; 1999 Jul; 163(1):137-42. PubMed ID: 10384109
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine phosphorylation and activation of Vav GTP/GDP exchange activity in antigen receptor-triggered B cells.
Gulbins E; Langlet C; Baier G; Bonnefoy-Berard N; Herbert E; Altman A; Coggeshall KM
J Immunol; 1994 Mar; 152(5):2123-9. PubMed ID: 8133029
[TBL] [Abstract][Full Text] [Related]
4. Vav-family proteins in T-cell signalling.
Tybulewicz VL
Curr Opin Immunol; 2005 Jun; 17(3):267-74. PubMed ID: 15886116
[TBL] [Abstract][Full Text] [Related]
5. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene.
Zhang R; Alt FW; Davidson L; Orkin SH; Swat W
Nature; 1995 Mar; 374(6521):470-3. PubMed ID: 7700359
[TBL] [Abstract][Full Text] [Related]
6. Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling.
Tedford K; Nitschke L; Girkontaite I; Charlesworth A; Chan G; Sakk V; Barbacid M; Fischer KD
Nat Immunol; 2001 Jun; 2(6):548-55. PubMed ID: 11376343
[TBL] [Abstract][Full Text] [Related]
7. Vav and the B cell signalosome.
DeFranco AL
Nat Immunol; 2001 Jun; 2(6):482-4. PubMed ID: 11376331
[No Abstract] [Full Text] [Related]
8. Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+ CD8+ thymocytes.
Fischer KD; Zmuldzinas A; Gardner S; Barbacid M; Bernstein A; Guidos C
Nature; 1995 Mar; 374(6521):474-7. PubMed ID: 7700360
[TBL] [Abstract][Full Text] [Related]
9. Dynamin 2 regulates T cell activation by controlling actin polymerization at the immunological synapse.
Gomez TS; Hamann MJ; McCarney S; Savoy DN; Lubking CM; Heldebrant MP; Labno CM; McKean DJ; McNiven MA; Burkhardt JK; Billadeau DD
Nat Immunol; 2005 Mar; 6(3):261-70. PubMed ID: 15696170
[TBL] [Abstract][Full Text] [Related]
10. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav.
Tarakhovsky A; Turner M; Schaal S; Mee PJ; Duddy LP; Rajewsky K; Tybulewicz VL
Nature; 1995 Mar; 374(6521):467-70. PubMed ID: 7700358
[TBL] [Abstract][Full Text] [Related]
11. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
Palmby TR; Abe K; Karnoub AE; Der CJ
Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
[TBL] [Abstract][Full Text] [Related]
12. Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation.
Doody GM; Bell SE; Vigorito E; Clayton E; McAdam S; Tooze R; Fernandez C; Lee IJ; Turner M
Nat Immunol; 2001 Jun; 2(6):542-7. PubMed ID: 11376342
[TBL] [Abstract][Full Text] [Related]
13. RhoG regulates gene expression and the actin cytoskeleton in lymphocytes.
Vigorito E; Billadeu DD; Savoy D; McAdam S; Doody G; Fort P; Turner M
Oncogene; 2003 Jan; 22(3):330-42. PubMed ID: 12545154
[TBL] [Abstract][Full Text] [Related]
14. Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells.
Fujikawa K; Miletic AV; Alt FW; Faccio R; Brown T; Hoog J; Fredericks J; Nishi S; Mildiner S; Moores SL; Brugge J; Rosen FS; Swat W
J Exp Med; 2003 Nov; 198(10):1595-608. PubMed ID: 14623913
[TBL] [Abstract][Full Text] [Related]
15. Lineage-specific requirement for the PH domain of Vav1 in the activation of CD4+ but not CD8+ T cells.
Prisco A; Vanes L; Ruf S; Trigueros C; Tybulewicz VL
Immunity; 2005 Sep; 23(3):263-74. PubMed ID: 16169499
[TBL] [Abstract][Full Text] [Related]
16. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction.
Holsinger LJ; Graef IA; Swat W; Chi T; Bautista DM; Davidson L; Lewis RS; Alt FW; Crabtree GR
Curr Biol; 1998 May; 8(10):563-72. PubMed ID: 9601640
[TBL] [Abstract][Full Text] [Related]
17. Constitutive tyrosine phosphorylation of the vav proto-oncogene product in MRL/Mp-lpr/lpr mice.
Mimura T; Minota S; Nojima Y; Morino N; Hamasaki K; Furuya H; Yazaki Y
J Immunol; 1997 Mar; 158(6):2977-83. PubMed ID: 9058837
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
Song JS; Haleem-Smith H; Arudchandran R; Gomez J; Scott PM; Mill JF; Tan TH; Rivera J
J Immunol; 1999 Jul; 163(2):802-10. PubMed ID: 10395673
[TBL] [Abstract][Full Text] [Related]
19. Vav: function and regulation in hematopoietic cell signaling.
Bonnefoy-Bérard N; Munshi A; Yron I; Wu S; Collins TL; Deckert M; Shalom-Barak T; Giampa L; Herbert E; Hernandez J; Meller N; Couture C; Altman A
Stem Cells; 1996 May; 14(3):250-68. PubMed ID: 8724692
[TBL] [Abstract][Full Text] [Related]
20. CD28 costimulation: a source of Vav-1 for TCR signaling with the help of SLP-76?
Michel F; Acuto O
Sci STKE; 2002 Aug; 2002(144):pe35. PubMed ID: 12165654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
